NCT03355976 2025-10-09BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell CarcinomasBrown UniversityPhase 2 Active not recruiting46 enrolled
NCT05032040 2025-02-07A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary MalignanciesXencor, Inc.Phase 2 Active not recruiting170 enrolled